Biogen Idec Announces Webcast of Neurodegeneration & Repair R&D Roundtable

Monday, November 22, 2010 4:26 pm EST

Dateline:

WESTON, Mass.

Public Company Information:

NASDAQ:
BIIB
US09062X1037

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its Neurodegeneration & Repair R&D Roundtable will be webcast live on Tuesday, November 30, 2010 at 11:30 a.m. ET. To access the live webcast, please visit Biogen Idec’s Investor Relations section (investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Biogen Idec uses cutting edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.

Contact:

Biogen Idec
Karen Jewell, 781-464-2066
Investor Relations